NIPRO ELISIO™ -H HEMODIALYZER ELISIO™-21HRecalls & reported problems
Nipro Medical Corporation · Surface area 2.1m² Max.TMP:66kPa(500mmHg) · Class 2
All models of NIPRO ELISIO -H HEMODIALYZER (5)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 9
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 9 adverse event reports that list this exact device (DI 00383790007122), received between Feb 20, 2019 and Mar 6, 2025 — classified as 3 injuries, 6 malfunctions.
The most frequently reported specific device problem is “Fluid/Blood Leak” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Fluid/Blood Leak4
- Adverse Event Without Identified Device or Use Problem2
- Obstruction of Flow2
- Leak/Splash1
Patient problems
- Insufficient Information3
- Abdominal Pain2
- Blood Loss2
- Anemia1
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 9 most recent of 9 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 6, 2025Fluid/Blood Leak; Fluid/Blood Leak
1.5 HOURS INTO DIALYSIS TREATMENT, MACHINE ALARMED FOR BLOOD LEAK. TREATMENT WAS INTERRUPTED AND PATIENT WAS MOVED TO A DIFFERENT MACHINE/SET-UP. APPROXIMATELY 250ML OF BLOOD LOSS. THE TEST STRIP WE USED WAS POSITIVE AND NO BLOOD WAS VISIBLE IN THE AFFLUENT DIALYSATE. WE HAD NO OTHER BLOOD LEAKS WITH THIS LOT NUMBER. ZOFRAN WAS ADMINISTERED TO THE PATIENT. THERE WERE NO MEDICAL INTERVENTIONS, HOWEVER PATIENT DID REQUIRE DIALYSIS ACCESS REVISION THE FOLLOWING DAY. DIALYSIS SETTINGS: BFR 350, DFR 600
Patient problems: Insufficient Information
MAUDE report 21537850 ↗MalfunctionMar 6, 2025Fluid/Blood Leak; Fluid/Blood Leak
1.5 HOURS INTO DIALYSIS TREATMENT, MACHINE ALARMED FOR BLOOD LEAK. TREATMENT WAS INTERRUPTED AND PATIENT WAS MOVED TO A DIFFERENT MACHINE/SET-UP. APPROXIMATELY 250ML OF BLOOD LOSS. THE TEST STRIP WE USED WAS POSITIVE AND NO BLOOD WAS VISIBLE IN THE AFFLUENT DIALYSATE. WE HAD NO OTHER BLOOD LEAKS WITH THIS LOT NUMBER. ZOFRAN WAS ADMINISTERED TO THE PATIENT. THERE WERE NO MEDICAL INTERVENTIONS, HOWEVER PATIENT DID REQUIRE DIALYSIS ACCESS REVISION THE FOLLOWING DAY. DIALYSIS SETTINGS: BFR 350, DFR 600.
Patient problems: Insufficient Information
MAUDE report 21537629 ↗MalfunctionApr 15, 2024Fluid/Blood Leak; Fluid/Blood Leak
15 MINUTES INTO HDF DIALYSIS TREATMENT, STAFF NOTICED BLOODLEAK IN THE DIALYZER. MACHINE DID NOT ALARM FOR ANY ISSUES, ONLY VAM (VENOUS ACCES MONITOR) ALARM WAS NOTED. THE FACILITY TESTED FOR BLOOD LEAK AND RESULTS WERE POSITIVE. PROPHYLACTIC ANTIBIOTICS WERE ADMINISTED. PER FACILITY, PATIENT HAS BEEN USING THE ELISIO-H DIALYZERS FOR THE PAST 4 YEARS. THE PRIMING PROCEDURES WERE ACCORDING TO THE FRESENIUS MACHINE FOR ONLINE PRIMING. DIALYSIS SETTING SWERE HDF POST DILUTION. STILL PENDING ADDITIONAL INFORMATION FROM FACILITY.
Patient problems: Insufficient Information
MAUDE report 19106768 ↗MalfunctionMay 27, 2021Obstruction of Flow; Obstruction of Flow
CLINIC STATED THAT THEY HAVE EXPERIENCED AN INCREASE IN CLOTTED DIALYZERS SINCE SWITCHING FROM OPTIFLUX DIALYZERS TO ELISIO DIALYZERS. TREATMENTS ARE INTERRUPTED, AND MOST ARE UNABLE TO RETURN THE PATIENT'S BLOOD.THE CLOTTING IS NOT PATIENT, DIALYZER SIZE, OR USER SPECIFIC. 3 TOTAL INCIDENTS: (B)(6) 2021 - 1 INCIDENT (PATIENT REQUIRED BLOOD TRANSFUSION ON (B)(6) 2021) (B)(6) 2021 - 1 INCIDENT (B)(6) 2021 - 1 INCIDENT CLINICAL SPECIALIST CONTACTED THE FACILITY AND OFFERED IN-PERSON PRODUCT TRAINING FOR MAY 3, 4, AND 5TH 2021. CLINIC WAS ADVISED TO FOLLOW IFU FOR PROPER PRIMING INSTRUCTIONS, BECAUSE THE STAFF WAS FOLLOWING CLINIC PROTOCOLS AND NOT THE PRODUCT IFU. AFTER OUR CLINICAL SPECIALIST VISITED THE CLINIC AND OBSERVED THE STAFF DURING PRIMING AND RECIRCULATING PROCESS, IT WAS IDENTIFIED THAT THE CLINIC WAS RECIRCULATING WITH 100ML INSTEAD OF 200ML AS INSTRUCTED IN THE IFU. ARTERIAL CHAMBERS WERE ALSO OBSERVED NOT BE BE 75% FULL IN SOME CASES. DURING HER VISIT TO THE CLINIC, THE NURSE MANAGER ADVISED THAT A PATIENT REQUIRED A BLOOD TRANSFUSION 2 DAYS AFTER TREATMENT WAS INTERRUPTED AND THE PATIENT'S BLOOD COULD NOT BE RETURNED DUE TO THE CLOTTED DIALYZER. ALL DATA WAS DOCUMENTE
Patient problems: Anemia
MAUDE report 11899052 ↗MalfunctionMay 27, 2021Obstruction of Flow; Obstruction of Flow
CLINIC STATED THAT THEY HAVE EXPERIENCED AN INCREASE IN CLOTTED DIALYZERS SINCE SWITCHING FROM OPTIFLUX DIALYZERS TO ELISIO DIALYZERS. TREATMENTS ARE INTERRUPTED, AND MOST ARE UNABLE TO RETURN THE PATIENT'S BLOOD. THE CLOTTING IS NOT PATIENT, DIALYZER SIZE, OR USER SPECIFIC. 3 TOTAL INCIDENTS: (B)(6) 2021- 1 INCIDENT (PATIENT REQUIRED BLOOD TRANSFUSION ON (B)(6) 2021); (B)(6) 2021- 1 INCIDENT; (B)(6) 2021- 1 INCIDENT. CLINICAL SPECIALIST CONTACTED THE FACILITY AND OFFERED IN-PERSON PRODUCT TRAINING FOR (B)(6) 2021. CLINIC WAS ADVISED TO FOLLOW IFU FOR PROPER PRIMING INSTRUCTIONS, BECAUSE THE STAFF WAS FOLLOWING CLINIC PROTOCOLS AND NOT THE PRODUCT IFU. AFTER OUR CLINICAL SPECIALIST VISITED THE CLINIC AND OBSERVED THE STAFF DURING PRIMING AND RECIRCULATING PROCESS, IT WAS IDENTIFIED THAT THE CLINIC WAS RECIRCULATING WITH 100ML INSTEAD OF 200ML AS INSTRUCTED IN THE IFU. ARTERIAL CHAMBERS WERE ALSO OBSERVED NOT BE 75% FULL IN SOME CASES. DURING HER VISIT TO THE CLINIC, THE NURSE MANAGER ADVISED THAT A PATIENT REQUIRED A BLOOD TRANSFUSION 2 DAYS AFTER TREATMENT WAS INTERRUPTED AND THE PATIENT'S BLOOD COULD NOT BE RETURNED DUE TO THE CLOTTED DIALYZER. ALL DATA WAS DOCUMENTED AND AN EMAI
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11899023 ↗InjuryDec 6, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2020, A 2ND PATIENT SENT TO THE ICU AFTER DIALYSIS TREATMENT. NO FURTHER INFORMATION WAS PROVIDED. UNKNOWN DETAILS OF ADVERSE EVENT OR PATIENT SYMPTOMS. CLINICAL SPECIALIST WILL CONTINUE TO ATTEMPT TO OBTAIN ADDITIONAL INFORMATION. ADDITIONAL INFORMATION RECEIVED ON 11/23/2020: PATIENT (B)(6); (B)(6)-YEAR-OLD FEMALE, STARTED DIALYSIS TREATMENT AT 630AM ON (B)(6) 2020, SET FOR 3.5H AS ORDERED, BP 104/65; HR 97. PATIENT COMPLAINED OF HEARTBURN DURING DIALYSIS. PATIENT STATED SHE HAS THIS OCCASIONALLY AT HOME AND TAKES SOME MEDS FOR IT. RENAL PHYSICIAN NOTIFIED OF PATIENT'S COMPLAINTS. PATIENT WAS STARTED ON OXYGEN 3L/NASAL CANNULA DUE TO COMPLAINTS OF SHORTNESS OF BREATH. O2(OXYGEN) SATURATION CHECKED, 100% WITH OXYGEN. PATIENT WAS RESTING DURING HD WITH NO FURTHER DISTRESS. AT APPROXIMATELY AN HOUR AND A HALF INTO TREATMENT, RENAL PHYSICIAN WAS MAKING ROUNDS, SEEN AND EXAMINED PATIENT, WITH ORDERS TO STOP HD, DRAW LABS: CBC, LIPASE, TROPONIN, ELECTROLYTES AND SENT TO EMERGENCY ROOM FOR FURTHER EVALUATION/TREATMENT. HD ENDED 2.5 HOURS INTO TREATMENT. NEEDLES WERE REMOVED WITH NO SEVERE BLEEDING. BP 118/68; HR 98; TEMP: 97.8. TREATMENT INFORMATION: NUMBER OF HOURS: 2.5 ACCES
Patient problems: Abdominal Pain
MAUDE report 10955690 ↗InjuryDec 6, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2020, THE 2ND PATIENT SENT TO THE ICU AFTER DIALYSIS TREATMENT. NO FURTHER INFORMATION WAS PROVIDED. UNKNOWN DETAILS OF ADVERSE EVENT OR PATIENT SYMPTOMS. CLINICAL SPECIALIST WILL CONTINUE TO ATTEMPT TO OBTAIN ADDITIONAL INFORMATION. ADDITIONAL INFORMATION RECEIVED 11/23/2020: PATIENT (B)(6), A (B)(6)-YEAR-OLD FEMALE, STARTED DIALYSIS TREATMENT AT 630AM ON (B)(6) 2020, SET FOR 3.5H AS ORDERED, BP 104/65; HR 97. PATIENT COMPLAINED OF HEARTBURN DURING DIALYSIS. PATIENT STATED SHE HAS THIS OCCASIONALLY AT HOME AND TAKES SOME MEDS FOR IT. RENAL PHYSICIAN NOTIFIED OF PATIENT'S COMPLAINTS. PATIENT WAS STARTED ON OXYGEN 3L/NASAL CANNULA DUE TO COMPLAINTS OF SHORTNESS OF BREATH. O2(OXYGEN) SATURATION CHECKED, 100% WITH OXYGEN. PATIENT WAS RESTING DURING HD WITH NO FURTHER DISTRESS. AT APPROXIMATELY AN HOUR AND A HALF INTO TREATMENT, RENAL PHYSICIAN WAS MAKING ROUNDS, SEEN AND EXAMINED PATIENT, WITH ORDERS TO STOP HD, DRAW LABS: CBC, LIPASE, TROPONIN, ELECTROLYTES AND SENT TO EMERGENCY ROOM FOR FURTHER EVALUATION/TREATMENT. HD ENDED 2.5 HOURS INTO TREATMENT. NEEDLES WERE REMOVED WITH NO SEVERE BLEEDING. BP 118/68; HR 98; TEMP: 97.8. TREATMENT INFORMATION: NUMBER OF HOURS: 2.5 ACCE
Patient problems: Abdominal Pain
MAUDE report 10955687 ↗MalfunctionFeb 20, 2019Leak/Splash; Leak/Splash
MACHINE ALARMED FOR BLOOD LEAK 15 MINUTES INTO DIALYSIS TREATMENT, BLOOD LEAK TEST STRIP WAS POSITIVE, TREATMENT STOPPED AND BLOOD WAS NOT RETURNED, PATIENT LOST ABOUT 200ML OF BLOOD. NEW MACHINE SET UP WAS STARTED, 5 MINUTES INTO DIALYSIS TREATMENT MACHINE ALARMED FOR BLOOD LEAK AGAIN AND TESTED BLOOD LEAK TEST STRIP WAS POSITIVE, TREATMENT WAS STOPPED, BLOOD WAS NOT RETURNED, PATIENT LOST ABOUT 200ML OF BLOOD AGAIN, A THIRD MACHINE SET UP WAS STARTED AGAIN, PATIENT FINISHED TREATMENT WITHOUT FURTHER PROBLEMS. SAME DIALZYER LOT NUMBER WAS USED FOR ALL 3 MACHINE SET UPS. SINCE THE BLOOD LEAK ALARMS, PATIENT HAS RETURNED FOR THEIR SCHEDULED DIALYSIS TREATMENTS WITHOUT COMPLICATIONS. DIALYSIS TREATMENT ORDER: 400 BLOOD FLOW RATE, 800 DIALYSATE FLOW RATE , TREATMENT TIME 4HRS AND 30MIN. OTHER DEVICES USED: DIALYSIS MACHINE: FRESENIUS T BLOODLINES: STREAMLINE.
Patient problems: Blood Loss
MAUDE report 8356034 ↗InjuryFeb 20, 2019Fluid/Blood Leak
MACHINE ALARMED FOR BLOOD LEAK 15 MINUTES INTO DIALYSIS TREATMENT, BLOOD LEAK TEST STRIP WAS POSITIVE, TREATMENT STOPPED AND BLOOD WAS NOT RETURNED, PATIENT LOST ABOUT 200ML OF BLOOD. NEW MACHINE SET UP WAS STARTED, 5 MINUTES INTO DIALYSIS TREATMENT MACHINE ALARMED FOR BLOOD LEAK AGAIN AND TESTED BLOOD LEAK TEST STRIP WAS POSITIVE, TREATMENT WAS STOPPED, BLOOD WAS NOT RETURNED, PATIENT LOST ABOUT 200ML OF BLOOD AGAIN, A THIRD MACHINE SET UP WAS STARTED AGAIN, PATIENT FINISHED TREATMENT WITHOUT FURTHER PROBLEMS. SAME DIALZYER LOT NUMBER WAS USED FOR ALL 3 MACHINE SET UPS. SINCE THE BLOOD LEAK ALARMS, PATIENT HAS RETURNED FOR THEIR SCHEDULED DIALYSIS TREATMENTS WITHOUT COMPLICATIONS. DIALYSIS TREATMENT ORDER: 400 BLOOD FLOW RATE, 800 DIALYSATE FLOW RATE , TREATMENT TIME 4HRS AND 30MIN. OTHER DEVICES USED: DIALYSIS MACHINE: FRESENIUS T, BLOODLINES: STREAMLINE.
Patient problems: Blood Loss
MAUDE report 8355987 ↗
Other Dialyzer, high permeability with or without sealed dialysate system devices
- Optiflux® 0500318EFresenius Medical Care Holdings, Inc. · Dialyzer, high permeability with or without sealed dialysate system1 recall6 deaths2,849 reports
- 2008® Series Hemodialysis Machines 190713Fresenius Usa, Inc. · Dialyzer, high permeability with or without sealed dialysate system3 recalls37 deaths893 reports
- 2008T BlueStar Hemodialysis Machine 191126Fresenius Medical Care Holdings, Inc. · Dialyzer, high permeability with or without sealed dialysate system5 recalls10 deaths441 reports
- 2008® Series Hemodialysis Machines 190766Fresenius Usa, Inc. · Dialyzer, high permeability with or without sealed dialysate system4 recalls15 deaths370 reports
- 2008T BlueStar Hemodialysis Machine 191130Fresenius Medical Care Holdings, Inc. · Dialyzer, high permeability with or without sealed dialysate system4 recalls7 deaths272 reports
- 2008® Series Hemodialysis Machines 190610Fresenius Usa, Inc. · Dialyzer, high permeability with or without sealed dialysate system1 recall15 deaths335 reports
- Optiflux® 0500320EFresenius Medical Care Holdings, Inc. · Dialyzer, high permeability with or without sealed dialysate system2 recalls242 reports
- REVACLEAR 300Gambro Renal Products, Inc. · Dialyzer, high permeability with or without sealed dialysate system3 recalls125 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page